Basic mechanisms of epileptogenesis in pediatric cortical dysplasia

CNS Neuroscience and Therapeutics

Volumn 21, Issue 2, 2015, Pages 92-103

  Abdijadid, Sara ^a   Mathern, Gary W ^b   Levine, Michael S ^a   Cepeda, Carlos ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Balloon cells; Cortical dysplasia; Dysmorphic neurons; Epileptogenesis; MTOR pathway

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMATE RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

BRAIN TISSUE; COGNITIVE DEFECT; CORTICAL DYSPLASIA; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPTOGENESIS; GRAY MATTER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PYRAMIDAL NERVE CELL; REVIEW; WHITE MATTER; ANIMAL; BRAIN; COMPLICATION; EPILEPSY; MALFORMATION OF CORTICAL DEVELOPMENT GROUP II; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP II; NEURONS; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 84921445492     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12345     Document Type: Review

References (147)

1. Kostovic I, Rakic P. Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol 1990;297:441-470.
2. Kostovic I, Rakic P. Cytology and time of origin of interstitial neurons in the white matter in infant and adult human and monkey telencephalon. J Neurocytol 1980;9:219-242.
3. Isaac JT, Feldmeyer D. Mechanisms of neocortical development. J Physiol 2009;587:1871-1872.
4. Lerner JT, Salamon N, Hauptman JS, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: A critical review and the UCLA experience. Epilepsia 2009;50:1310-1335.
5. Hauptman JS, Mathern GW. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia 2012;53(Suppl. 4):98-104.
6. Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971;34:369-387.
7. Palmini A, Andermann F, Olivier A, et al. Neuronal migration disorders: A contribution of modern neuroimaging to the etiologic diagnosis of epilepsy. Can J Neurol Sci 1991;18:580-587.
8. Alonso-Nanclares L, Garbelli R, Sola RG, et al. Microanatomy of the dysplastic neocortex from epileptic patients. Brain 2005;128:158-173.
9. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-174.
10. Cepeda C, Hurst RS, Flores-Hernandez J, et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003;72:472-486.
11. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-153.
12. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62:S2-S8.
13. Mathern GW, Cepeda C, Hurst RS, Flores-Hernandez J, Mendoza D, Levine MS. Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia. Epilepsia 2000;41(Suppl. 6):S162-S167.
14. De Rosa MJ, Farrell MA, Burke MM, Secor DL, Vinters HV. An assessment of the proliferative potential of 'balloon cells' in focal cortical resections performed for childhood epilepsy. Neuropathol Appl Neurobiol 1992;18:566-574.
15. Andre VM, Cepeda C, Vinters HV, Huynh M, Mathern GW, Levine MS. Interneurons, GABAA currents, and subunit composition of the GABAA receptor in type I and type II cortical dysplasia. Epilepsia 2010;51(Suppl. 3):166-170.
16. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: Update 2012. Brain 2012;135:1348-1369.
17. Krsek P, Pieper T, Karlmeier A, et al. Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia 2009;50:125-137.
18. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: Neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002;125:1719-1732.
19. Spreafico R, Battaglia G, Arcelli P, et al. Cortical dysplasia: An immunocytochemical study of three patients. Neurology 1998;50:27-36.
20. Chassoux F, Devaux B, Landre E, et al. Stereoelectroencephalography in focal cortical dysplasia: A 3D approach to delineating the dysplastic cortex. Brain 2000;123(Pt 8):1733-1751.
21. Nobili L, Cardinale F, Magliola U, et al. Taylor's focal cortical dysplasia increases the risk of sleep-related epilepsy. Epilepsia 2009;50:2599-2604.
22. Lawson JA, Birchansky S, Pacheco E, et al. Distinct clinicopathologic subtypes of cortical dysplasia of Taylor. Neurology 2005;64:55-61.
23. Krsek P, Maton B, Jayakar P, et al. Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome. Neurology 2009;72:217-223.
24. Hemb M, Velasco TR, Parnes MS, et al. Improved outcomes in pediatric epilepsy surgery: The UCLA experience, 1986-2008. Neurology 2010;74:1768-1775.
25. Berg AT, Mathern GW, Bronen RA, et al. Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy. Brain 2009;132:2785-2797.
26. Harvey AS, Cross JH, Shinnar S, Mathern BW, Taskforce IPESS. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia 2008;49:146-155.
27. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-1077.
28. Barkovich AJ, Kuzniecky RI, Bollen AW, Grant PE. Focal transmantle dysplasia: A specific malformation of cortical development. Neurology 1997;49:1148-1152.
29. Colombo N, Tassi L, Deleo F, et al. Focal cortical dysplasia type IIa and IIb: MRI aspects in 118 cases proven by histopathology. Neuroradiology 2012;54:1065-1077.
30. Colombo N, Tassi L, Galli C, et al. Focal cortical dysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy. AJNR Am J Neuroradiol 2003;24:724-733.
31. Fauser S, Schulze-Bonhage A, Honegger J, et al. Focal cortical dysplasias: Surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain 2004;127:2406-2418.
32. Chung CK, Lee SK, Kim KJ. Surgical outcome of epilepsy caused by cortical dysplasia. Epilepsia 2005;46(Suppl. 1):25-29.
33. Widdess-Walsh P, Jeha L, Nair D, Kotagal P, Bingaman W, Najm I. Subdural electrode analysis in focal cortical dysplasia: Predictors of surgical outcome. Neurology 2007;69:660-667.
34. Chassoux F, Landre E, Mellerio C, et al. Type II focal cortical dysplasia: Electroclinical phenotype and surgical outcome related to imaging. Epilepsia 2012;53:349-358.
35. Mellerio C, Labeyrie MA, Chassoux F, et al. 3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia 2014;55:117-122.
36. Kurian M, Spinelli L, Delavelle J, et al. Multimodality imaging for focus localization in pediatric pharmacoresistant epilepsy. Epileptic Disord 2007;9:20-31.
37. von Oertzen TJ, Mormann F, Urbach H, et al. Prospective use of subtraction ictal SPECT coregistered to MRI (SISCOM) in presurgical evaluation of epilepsy. Epilepsia 2011;52:2239-2248.
38. Salamon N, Kung J, Shaw SJ, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology 2008;71:1594-1601.
39. Velasco TR, Wichert-Ana L, Mathern GW, et al. Utility of ictal single photon emission computed tomography in mesial temporal lobe epilepsy with hippocampal atrophy: A randomized trial. Neurosurgery 2011;68:431-436; discussion 6.
40. Krsek P, Kudr M, Jahodova A, et al. Localizing value of ictal SPECT is comparable to MRI and EEG in children with focal cortical dysplasia. Epilepsia 2013;54:351-358.
41. Chassoux F, Semah F, Bouilleret V, et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: A correlative study. Brain 2004;127:164-174.
42. Palmini A, Gambardella A, Andermann F, et al. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995;37:476-487.
43. Gambardella A, Palmini A, Andermann F, et al. Usefulness of focal rhythmic discharges on scalp EEG of patients with focal cortical dysplasia and intractable epilepsy. Electroencephalogr Clin Neurophysiol 1996;98:243-249.
44. Wu JY, Sankar R, Lerner JT, Matsumoto JH, Vinters HV, Mathern GW. Removing interictal fast ripples on electrocorticography linked with seizure freedom in children. Neurology 2010;75:1686-1694.
45. Kerber K, LeVan P, Dumpelmann M, et al. High frequency oscillations mirror disease activity in patients with focal cortical dysplasia. Epilepsia 2013;54:1428-1436.
46. Fujiwara H, Greiner HM, Lee KH, et al. Resection of ictal high-frequency oscillations leads to favorable surgical outcome in pediatric epilepsy. Epilepsia 2012;53:1607-1617.
47. Zecevic N, Chen Y, Filipovic R. Contributions of cortical subventricular zone to the development of the human cerebral cortex. J Comp Neurol 2005;491:109-122.
48. Wu Q, Liu J, Fang A, et al. The dynamics of neuronal migration. Adv Exp Med Biol 2014;800:25-36.
49. Lui JH, Hansen DV, Kriegstein AR. Development and evolution of the human neocortex. Cell 2011;146:18-36.
50. Marin-Padilla M. Cajal-Retzius cells and the development of the neocortex. Trends Neurosci 1998;21:64-71.
51. Super H, Uylings HB. The early differentiation of the neocortex: A hypothesis on neocortical evolution. Cereb Cortex 2001;11:1101-1109.
52. Forster E. Reelin, neuronal polarity and process orientation of cortical neurons. Neuroscience 2014;269:102-111.
53. Curran T, D'Arcangelo G. Role of reelin in the control of brain development. Brain Res Brain Res Rev 1998;26:285-294.
54. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995;374:719-723.
55. Kirischuk S, Luhmann HJ, Kilb W. Cajal-Retzius cells: Update on structural and functional properties of these mystic neurons that bridged the 20th century. Neuroscience 2014;275C:33-46.
56. Garbelli R, Frassoni C, Ferrario A, Tassi L, Bramerio M, Spreafico R. Cajal-Retzius cell density as marker of type of focal cortical dysplasia. NeuroReport 2001;12:2767-2771.
57. Zamecnik J, Homola A, Cicanic M, et al. The extracellular matrix and diffusion barriers in focal cortical dysplasias. Eur J Neurosci 2012;36:2017-2024.
58. Andres M, Andre VM, Nguyen S, et al. Human cortical dysplasia and epilepsy: An ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. Cereb Cortex 2005;15:194-210.
59. Mathern GW, Andres M, Salamon N, et al. A hypothesis regarding the pathogenesis and epileptogenesis of pediatric cortical dysplasia and hemimegalencephaly based on MRI cerebral volumes and NeuN cortical cell densities. Epilepsia 2007;48(Suppl. 5):74-78.
60. Chandra PS, Salamon N, Nguyen ST, et al. Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia. Neurology 2007;68:438-445.
61. Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM. Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol 2005;110:383-392.
62. Spreafico R, Pasquier B, Minotti L, et al. Immunocytochemical investigation on dysplastic human tissue from epileptic patients. Epilepsy Res 1998;32:34-48.
63. Palmini A, Paglioli E, Silva VD. Developmental tumors and adjacent cortical dysplasia: Single or dual pathology? Epilepsia 2013;54(Suppl. 9):18-24.
64. Hadjivassiliou G, Martinian L, Squier W, et al. The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy. Acta Neuropathol 2010;120:517-528.
65. Fauser S, Haussler U, Donkels C, et al. Disorganization of neocortical lamination in focal cortical dysplasia is brain-region dependent: Evidence from layer-specific marker expression. Acta Neuropathol Commun 2013;1:47.
66. Rossini L, Medici V, Tassi L, et al. Layer-specific gene expression in epileptogenic type II focal cortical dysplasia: Normal-looking neurons reveal the presence of a hidden laminar organization. Acta Neuropathol Commun 2014;2:45.
67. Andre VM, Wu N, Yamazaki I, et al. Cytomegalic interneurons: A new abnormal cell type in severe pediatric cortical dysplasia. J Neuropathol Exp Neurol 2007;66:491-504.
68. Cepeda C, Andre VM, Wu N, et al. Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia. Epilepsia 2007;48(Suppl. 5):79-85.
69. Cepeda C, Andre VM, Yamazaki I, et al. Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II. Epilepsia 2010;51(Suppl. 3):160-165.
70. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol 1994;87:493-503.
71. Vinters HV, Fisher RS, Cornford ME, et al. Morphological substrates of infantile spasms: Studies based on surgically resected cerebral tissue. Childs Nerv Syst 1992;8:8-17.
72. Sisodiya SM, Fauser S, Cross JH, Thom M. Focal cortical dysplasia type II: Biological features and clinical perspectives. Lancet Neurol 2009;8:830-843.
73. Cepeda C, Andre VM, Hauptman JS, et al. Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex. Neurobiol Dis 2012;45:310-321.
74. Crino PB. The pathophysiology of tuberous sclerosis complex. Epilepsia 2010;51(Suppl. 1):27-29.
75. Orlova KA, Crino PB. The tuberous sclerosis complex. Ann N Y Acad Sci 2010;1184:87-105.
76. Jozwiak J, Kotulska K, Jozwiak S. Similarity of balloon cells in focal cortical dysplasia to giant cells in tuberous sclerosis. Epilepsia 2006;47:805.
77. Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 2008;63:454-465.
78. Avoli M, Mattia D, Olivier A. A window on the physiopathogenesis of seizures in patients with cortical dysplasia. Adv Exp Med Biol 2002;497:123-132.
79. Mattia D, Olivier A, Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 1995;45:1391-1395.
80. Avoli M, Bernasconi A, Mattia D, Olivier A, Hwa GG. Epileptiform discharges in the human dysplastic neocortex: In vitro physiology and pharmacology. Ann Neurol 1999;46:816-826.
81. D'Antuono M, Louvel J, Kohling R, et al. GABAA receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex. Brain 2004;127:1626-1640.
82. Cepeda C, Andre VM, Flores-Hernandez J, et al. Pediatric cortical dysplasia: Correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits. Dev Neurosci 2005;27:59-76.
83. Andre VM, Flores-Hernandez J, Cepeda C, et al. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 2004;14:634-646.
84. Andre VM, Cepeda C, Vinters HV, Huynh M, Mathern GW, Levine MS. Pyramidal cell responses to gamma-aminobutyric acid differ in type I and type II cortical dysplasia. J Neurosci Res 2008;86:3151-3162.
85. Cepeda C, Andre VM, Vinters HV, Levine MS, Mathern GW. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia 2005;46(Suppl. 5):82-88.
86. Battaglia G, Colciaghi F, Finardi A, Nobili P. Intrinsic epileptogenicity of dysplastic cortex: Converging data from experimental models and human patients. Epilepsia 2013;54(Suppl. 6):33-36.
87. Tassi L, Pasquier B, Minotti L, et al. Cortical dysplasia: Electroclinical, imaging, and neuropathologic study of 13 patients. Epilepsia 2001;42:1112-1123.
88. Ying Z, Babb TL, Mikuni N, Najm I, Drazba J, Bingaman W. Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex. Exp Neurol 1999;159:409-418.
89. Najm IM, Ying Z, Babb T, et al. Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 2000;41:971-976.
90. Mikuni N, Babb TL, Ying Z, et al. NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia 1999;40:1683-1687.
91. Yamanouchi H. Activated remodeling and N-methyl-D-aspartate (NMDA) receptors in cortical dysplasia. J Child Neurol 2005;20:303-307.
92. Moddel G, Jacobson B, Ying Z, et al. The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res 2005;1046:10-23.
93. Ben-Ari Y, Cherubini E, Krnjevic K. Changes in voltage dependence of NMDA currents during development. Neurosci Lett 1988;94:88-92.
94. Cepeda C, Andre VM, Levine MS, et al. Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis. Epilepsy Behav 2006;9:219-235.
95. Babb TL, Ying Z, Hadam J, Penrod C. Glutamate receptor mechanisms in human epileptic dysplastic cortex. Epilepsy Res 1998;32:24-33.
96. Hilbig A, Babb TL, Najm I, Ying Z, Wyllie E, Bingaman W. Focal cortical dysplasia in children. Dev Neurosci 1999;21:271-280.
97. Aronica E, Gorter JA, Ijlst-Keizers H, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins. Eur J Neurosci 2003;17:2106-2118.
98. Calcagnotto ME, Paredes MF, Tihan T, Barbaro NM, Baraban SC. Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 2005;25:9649-9657.
99. Cherubini E, Gaiarsa JL, Ben-Ari Y. GABA: An excitatory transmitter in early postnatal life. Trends Neurosci 1991;14:515-519.
100. Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R. GABA: A pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 2007;87:1215-1284.
101. Cepeda C, Chen JY, Wu JY, et al. Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia. Neurobiol Dis 2014;62:208-217.
102. Talos DM, Sun H, Kosaras B, et al. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol 2012;71:539-551.
103. Marin-Valencia I, Guerrini R, Gleeson JG. Pathogenetic mechanisms of focal cortical dysplasia. Epilepsia 2014;55:970-978.
104. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-487.
105. Miyata H, Chiang AC, Vinters HV. Insulin signaling pathways in cortical dysplasia and TSC-tubers: Tissue microarray analysis. Ann Neurol 2004;56:510-519.
106. Ljungberg MC, Bhattacharjee MB, Lu Y, et al. Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 2006;60:420-429.
107. Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012;44:941-945.
108. Becker AJ, Urbach H, Scheffler B, et al. Focal cortical dysplasia of Taylor's balloon cell type: Mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29-37.
109. Sarnat HB, Flores-Sarnat L. Radial microcolumnar cortical architecture: Maturational arrest or cortical dysplasia? Pediatr Neurol 2013;48:259-270.
110. Arai A, Saito T, Hanai S, et al. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: Unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly. Brain Res 2012;1470:89-97.
111. Sakakibara T, Sukigara S, Saito T, et al. Delayed maturation and differentiation of neurons in focal cortical dysplasia with the transmantle sign: Analysis of layer-specific marker expression. J Neuropathol Exp Neurol 2012;71:741-749.
112. Orlova KA, Tsai V, Baybis M, et al. Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol 2010;69:850-863.
113. Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol 2005;109:519-533.
114. Hanai S, Saito T, Nakagawa E, et al. Abnormal maturation of non-dysmorphic neurons in focal cortical dysplasia: Immunohistochemical considerations. Seizure 2010;19:274-279.
115. Han CW, Min BW, Kim Y, et al. Immunohistochemical analysis of developmental neural antigen expression in the balloon cells of focal cortical dysplasia. J Clin Neurosci 2011;18:114-118.
116. Lamparello P, Baybis M, Pollard J, et al. Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain 2007;130:2267-2276.
117. Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Epilepsia 2005;46:1716-1723.
118. Gonzalez-Martinez JA, Ying Z, Prayson R, Bingaman W, Najm I. Glutamate clearance mechanisms in resected cortical dysplasia. J Neurosurg 2011;114:1195-1202.
119. Thom M, Martinian L, Sen A, et al. An investigation of the expression of G1-phase cell cycle proteins in focal cortical dysplasia type IIB. J Neuropathol Exp Neurol 2007;66:1045-1055.
120. Mizuguchi M, Yamanouchi H, Becker LE, Itoh M, Takashima S. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol 2002;104:418-424.
121. Aronica E, Boer K, Redeker S, et al. Differential expression patterns of chloride transporters, Na+-K + -2Cl-cotransporter and K + -Cl-cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience 2007;145:185-196.
122. Munakata M, Watanabe M, Otsuki T, et al. Altered distribution of KCC2 in cortical dysplasia in patients with intractable epilepsy. Epilepsia 2007;48:837-844.
123. Ben-Ari Y. The developing cortex. Handb Clin Neurol 2013;111:417-426.
124. Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: Emerging mechanisms. Nat Rev Neurol 2009;5:380-391.
125. Ben-Ari Y. Developing networks play a similar melody. Trends Neurosci 2001;24:353-360.
126. Moore AR, Zhou WL, Jakovcevski I, Zecevic N, Antic SD. Spontaneous electrical activity in the human fetal cortex in vitro. J Neurosci 2011;31:2391-2398.
127. Yu S, Li S, Shu H, et al. Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb. NeuroReport 2012;23:407-411.
128. Traub RD, Whittington MA, Buhl EH, et al. A possible role for gap junctions in generation of very fast EEG oscillations preceding the onset of, and perhaps initiating, seizures. Epilepsia 2001;42:153-170.
129. Gigout S, Louvel J, Kawasaki H, et al. Effects of gap junction blockers on human neocortical synchronization. Neurobiol Dis 2006;22:496-508.
130. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 2007;448:901-907.
131. Cepeda C, Walsh JP, Peacock W, Buchwald NA, Levine MS. Dye-coupling in human neocortical tissue resected from children with intractable epilepsy. Cereb Cortex 1993;3:95-107.
132. Boonyapisit K, Najm I, Klem G, et al. Epileptogenicity of focal malformations due to abnormal cortical development: Direct electrocorticographic-histopathologic correlations. Epilepsia. 2003;44:69-76.
133. Garbelli R, Frassoni C, Condorelli DF, et al. Expression of connexin 43 in the human epileptic and drug-resistant cerebral cortex. Neurology 2011;76:895-902.
134. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: Excitability and inflammation. Trends Neurosci 2013;36:174-184.
135. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB. Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 2012;72:881-892.
136. Spangle JM, Munger K. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 2010;84:9398-9407.
137. Teissier N, Fallet-Bianco C, Delezoide AL, et al. Cytomegalovirus-induced brain malformations in fetuses. J Neuropathol Exp Neurol 2014;73:143-158.
138. Leventer RJ, Jansen FE, Mandelstam SA, et al. Is focal cortical dysplasia sporadic? Family evidence for genetic susceptibility Epilepsia 2014;55:e22-e26.
139. Cleary RT, Sun H, Huynh T, et al. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. PLoS ONE 2013;8:e57148.
140. Puskarjov M, Kahle KT, Ruusuvuori E, Kaila K. Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures. Epilepsia 2014;55:806-818.
141. Dzhala VI, Brumback AC, Staley KJ. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 2008;63:222-235.
142. Dzhala VI, Talos DM, Sdrulla DA, et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005;11:1205-1213.
143. Galanopoulou AS, Gorter JA, Cepeda C. Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target. Epilepsia 2012;53:1119-1130.
144. Pasnicu A, Denoyer Y, Haegelen C, Pasqualini E, Biraben A. Modulation of paroxysmal activity in focal cortical dysplasia by centromedian thalamic nucleus stimulation. Epilepsy Res 2013;104:264-268.
145. Morrell MJ, Group RNSSiES. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77:1295-1304.
146. Jensen FE. Epilepsy in 2013: Progress across the spectrum of epilepsy research. Nat Rev Neurol 2014;10:63-64.
147. Paz JT, Davidson TJ, Frechette ES, et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat Neurosci 2013;16:64-70.